Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083979 · ClinicalTrials.gov registry record · NA

Intravesical Liposomes for Ulcerative Cystitis

A NA study, sponsored by Kenneth Peters, MD.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT01083979 is a NA study that has completed, run by Kenneth Peters, MD. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083979, a NA study, has completed, sponsored by Kenneth Peters, MD.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The objective is to instill liposomes reconstituted with sterile water into the bladder as a compassionate use treatment in one patient with ulcerative interstitial cystitis (IC).

Interventions

  • DRUG Liposomes

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2010-08
Est. Completion 2010-10
Phase NA

Sponsor

Kenneth Peters, MD

14 total trials

What the Registry Record Tells You About NCT01083979

The ClinicalTrials.gov registry entry for NCT01083979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kenneth Peters, MD, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Liposomes is the first listed.

NCT01083979 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01083979 about?

NCT01083979 is a clinical study titled "Intravesical Liposomes for Ulcerative Cystitis". The objective is to instill liposomes reconstituted with sterile water into the bladder as a compassionate use treatment in one patient with ulcerative interstitial cystitis (IC).

What is the current status of trial NCT01083979?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2010-08. Estimated completion is 2010-10.

What interventions are being tested in trial NCT01083979?

The interventions under investigation include: Liposomes (DRUG).

Who is sponsoring clinical trial NCT01083979?

This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.